周五午后，港股创新药概念股拉升。信达生物 涨近13%，消息面上，信达生物公告称，已与辉瑞达成全球战略许可及合作协议，聚焦12个突破性肿瘤早期及源头创新研发项目，交易总额最高达105亿美元。
同时， 石药集团 、 荣昌生物 涨7%， 诺诚健华 涨超5%。
周五午后，港股创新药概念股拉升。信达生物 涨近13%，消息面上，信达生物公告称，已与辉瑞达成全球战略许可及合作协议，聚焦12个突破性肿瘤早期及源头创新研发项目，交易总额最高达105亿美元。
同时， 石药集团 、 荣昌生物 涨7%， 诺诚健华 涨超5%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
